D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.76% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Tetra Tech
TTEK
$8.7B
| $3.29M | ﹤0.01% |
+98,545
| New | +$3.15M |
|
|
ZLS
2127
DELISTED
Zalatoris II Acquisition Corp Class A Ordinary Shares
ZLS
| $3.28M | ﹤0.01% |
308,000
| – | – |
|
2128
Reynolds Consumer Products
REYN
$5.44B
| $3.28M | ﹤0.01% |
122,091
+48,124
| +65% | +$1.26M |
|
2129
PUT
Herc Holdings
HRI
$4.95B
| $3.28M | ﹤0.01% |
22,000
| – | – |
|
2130
The Joint Corp
JYNT
$123M
| $3.28M | ﹤0.01% |
340,806
-32,440
| -9% | -$281K |
|
2131
CALL
Southern Company
SO
$109B
| $3.27M | ﹤0.01% |
46,700
| – | – |
|
2132
PUT
Upstart Holdings
UPST
$2.66B
| $3.27M | ﹤0.01% |
80,000
-330,000
| -80% | -$10M |
|
2133
Commault Systems
CVLT
$4.97B
| $3.27M | ﹤0.01% |
40,913
-6,450
| -14% | -$461K |
|
|
CSW
2134
CSW Industrials
CSW
$4.87B
| $3.27M | ﹤0.01% |
15,748
+840
| +6% | +$152K |
|
2135
Seaboard Corp
SEB
$4.36B
| $3.26M | ﹤0.01% |
914
+4
| +0.4% | +$14.2K |
|
2136
Altimmune
ALT
$581M
| $3.26M | ﹤0.01% |
289,726
-441,006
| -60% | -$1.84M |
|
|
SRCL
2137
DELISTED
Stericycle Inc
SRCL
| $3.26M | ﹤0.01% |
65,744
-46,730
| -42% | -$2.1M |
|
2138
PUT
Erie Indemnity
ERIE
$12.7B
| $3.25M | ﹤0.01% |
+9,700
| New | +$2.91M |
|
|
GTM
2139
ZoomInfo Technologies
GTM
$967M
| $3.24M | ﹤0.01% |
175,122
+104,841
| +149% | +$1.64M |
|
|
MNTN
2140
DELISTED
Everest Consolidator Acquisition Corporation
MNTN
| $3.24M | ﹤0.01% |
295,806
| – | – |
|
2141
Vera Therapeutics
VERA
$2.39B
| $3.23M | ﹤0.01% |
210,039
+51,853
| +33% | +$659K |
|
2142
PUT
Bio-Rad Laboratories Class A
BIO
$8.86B
| $3.23M | ﹤0.01% |
10,000
| – | – |
|
2143
DuPont de Nemours
DD
$19B
| $3.22M | ﹤0.01% |
33,317
-66,814
| -67% | -$6.08M |
|
2144
NCR Voyix
VYX
$1.19B
| $3.21M | ﹤0.01% |
190,082
-144,048
| -43% | -$2.3M |
|
2145
J.M. Smucker
SJM
$13.2B
| $3.21M | ﹤0.01% |
25,401
+1,730
| +7% | +$200K |
|
2146
Avantor
AVTR
$8.48B
| $3.21M | ﹤0.01% |
140,599
+113,766
| +424% | +$2.33M |
|
2147
CALL
ZTO Express
ZTO
$18.2B
| $3.19M | ﹤0.01% |
150,000
+40,000
| +36% | +$908K |
|
2148
Helix Energy Solutions
HLX
$1.35B
| $3.19M | ﹤0.01% |
310,495
-59,486
| -16% | -$591K |
|
2149
Campbell Soup
CPB
$6.8B
| $3.19M | ﹤0.01% |
73,694
-13,832
| -16% | -$569K |
|
2150
PUT
Asana
ASAN
$1.89B
| $3.18M | ﹤0.01% |
167,500
| – | – |
|
Similar funds
D.E. Shaw & Co's Q4 2023 Portfolio in Review
As of Q4 2023, D.E. Shaw & Co held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- D.E. Shaw & Co added most to Netflix in Q4 2023, an estimated $751M increase.
- D.E. Shaw & Co's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- D.E. Shaw & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- D.E. Shaw & Co opened 575 new positions and closed 527 in Q4 2023.
- D.E. Shaw & Co's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.